(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SRD5A1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine multiple interactions ISO RGD:11341 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SRD5A1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:11341 6480464 1, 2-Dimethylhydrazine results in decreased expression of SRD5A1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SRD5A1 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SRD5A1 mRNA CTD PMID:16940010 17beta-hydroxy-5alpha-androstan-3-one affects expression EXP 6480464 Dihydrotestosterone affects the expression of SRD5A1 mRNA CTD PMID:22131296 17beta-hydroxy-5alpha-androstan-3-one increases chemical synthesis EXP 6480464 SRD5A1 protein results in increased chemical synthesis of Dihydrotestosterone CTD PMID:28535922 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:736446 6480464 AR protein affects the reaction [vinclozolin inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A1 mRNA]], vinclozolin inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A1 mRNA] CTD PMID:25324206 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736446 6480464 Dihydrotestosterone results in increased expression of SRD5A1 mRNA CTD PMID:25324206 more ... 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 [SRD5A1 protein results in increased metabolism of Testosterone] which results in increased chemical synthesis of Dihydrotestosterone CTD PMID:28535922 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 , PMID:19464308 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11341 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SRD5A1 mRNA] CTD PMID:16984957 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SRD5A1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11341 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRD5A1 mRNA CTD PMID:16984957 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRD5A1 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11341 6480464 Tetrachlorodibenzodioxin affects the expression of SRD5A1 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SRD5A1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SRD5A1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:736446 6480464 beta-methylcholine affects the expression of SRD5A1 mRNA CTD PMID:21179406 3',5'-cyclic AMP increases expression ISO RGD:11341 6480464 Cyclic AMP results in increased expression of SRD5A1 mRNA CTD PMID:25576683 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:11341 6480464 tetrabromobisphenol A results in increased expression of SRD5A1 mRNA CTD PMID:25576683 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SRD5A1 mRNA CTD PMID:28522335 3alpha-hydroxy-5beta-pregnan-20-one increases chemical synthesis ISO RGD:736446 6480464 SRD5A1 protein results in increased chemical synthesis of Pregnanolone CTD PMID:25463305 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of SRD5A1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SRD5A1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:11341 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SRD5A1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:11341 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SRD5A1 mRNA CTD PMID:25576683 4,4'-sulfonyldiphenol decreases expression ISO RGD:11341 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of SRD5A1 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:11341 6480464 Fenretinide results in increased expression of SRD5A1 mRNA CTD PMID:28973697 5alpha-Pregnan-20alpha-ol-3-one increases chemical synthesis ISO RGD:736446 6480464 SRD5A1 protein results in increased chemical synthesis of allopregnan-20 alpha-ol-3-one CTD PMID:25463305 5alpha-pregnane-3,20-dione multiple interactions ISO RGD:736446 6480464 [SRD5A1 protein results in increased metabolism of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:23183084 5alpha-pregnane-3,20-dione increases chemical synthesis ISO RGD:736446 6480464 SRD5A1 protein results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:25463305 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SRD5A1 mRNA CTD PMID:24780913 , PMID:25825206 8-Br-cAMP increases expression ISO RGD:11341 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SRD5A1 mRNA CTD PMID:24014645 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SRD5A1 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SRD5A1 mRNA CTD PMID:22459607 acrylamide increases expression ISO RGD:736446 6480464 Acrylamide results in increased expression of SRD5A1 mRNA CTD PMID:32763439 afimoxifene increases expression ISO RGD:736446 6480464 afimoxifene results in increased expression of SRD5A1 mRNA CTD PMID:16849584 all-trans-retinoic acid decreases expression ISO RGD:736446 6480464 Tretinoin results in decreased expression of SRD5A1 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SRD5A1 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:736446 6480464 Antimycin A results in decreased expression of SRD5A1 mRNA CTD PMID:33512557 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SRD5A1 mRNA, Chlorodiphenyl (54% Chlorine) results in decreased expression of SRD5A1 protein CTD PMID:18178546 , PMID:29208485 arsenous acid decreases expression ISO RGD:736446 6480464 Arsenic Trioxide results in decreased expression of SRD5A1 mRNA CTD PMID:19769630 atrazine decreases expression ISO RGD:11341 6480464 Atrazine results in decreased expression of SRD5A1 mRNA CTD PMID:23591565 azoxystrobin decreases expression ISO RGD:736446 6480464 azoxystrobin results in decreased expression of SRD5A1 mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO RGD:11341 6480464 Benzo(a)pyrene results in increased expression of SRD5A1 mRNA CTD PMID:27195522 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SRD5A1 mRNA CTD PMID:18164116 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of SRD5A1 mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of SRD5A1 mRNA CTD PMID:19560483 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SRD5A1 mRNA, bisphenol A results in decreased expression of SRD5A1 protein CTD PMID:23405234 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SRD5A1 mRNA CTD PMID:30903817 Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of SRD5A1 mRNA, bisphenol B results in increased expression of SRD5A1 protein CTD PMID:33940105 bisphenol F increases expression ISO RGD:11341 6480464 4, 4'-bisphenol F results in increased expression of SRD5A1 mRNA CTD PMID:25576683 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of SRD5A1 mRNA CTD PMID:19560483 cadmium atom increases expression ISO RGD:736446 6480464 Cadmium results in increased expression of SRD5A1 mRNA CTD PMID:24376830 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SRD5A1 mRNA, Cadmium Chloride results in increased expression of SRD5A1 protein CTD PMID:25993096 , PMID:29214744 carbon nanotube decreases expression ISO RGD:11341 6480464 Nanotubes more ... CTD PMID:25620056 chlordecone increases expression ISO RGD:11341 6480464 Chlordecone results in increased expression of SRD5A1 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:11341 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of SRD5A1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SRD5A1 gene CTD PMID:20938992 , PMID:29127188 chromium(6+) multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of SRD5A1 protein CTD PMID:33675932 ciguatoxin CTX1B affects expression ISO RGD:11341 6480464 Ciguatoxins affects the expression of SRD5A1 mRNA CTD PMID:18353800 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SRD5A1 mRNA CTD PMID:17602206 colforsin daropate hydrochloride increases expression ISO RGD:11341 6480464 Colforsin results in increased expression of SRD5A1 mRNA CTD PMID:22461451 copper(II) sulfate decreases expression ISO RGD:736446 6480464 Copper Sulfate results in decreased expression of SRD5A1 mRNA CTD PMID:19549813 cumene multiple interactions ISO RGD:11341 6480464 [cumene co-treated with KRAS gene mutant form] results in decreased expression of SRD5A1 mRNA CTD PMID:18648096 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SRD5A1 mRNA CTD PMID:27523638 cyproconazole increases expression ISO RGD:11341 6480464 cyproconazole results in increased expression of SRD5A1 mRNA CTD PMID:22334560 D-aspartic acid increases expression EXP 6480464 D-Aspartic Acid results in increased expression of SRD5A1 mRNA CTD PMID:26044185 dehydroepiandrosterone affects metabolic processing EXP 6480464 SRD5A1 protein affects the metabolism of Dehydroepiandrosterone CTD PMID:15261307 diarsenic trioxide decreases expression ISO RGD:736446 6480464 Arsenic Trioxide results in decreased expression of SRD5A1 mRNA CTD PMID:19769630 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SRD5A1 mRNA CTD PMID:19560483 diclofenac decreases expression ISO RGD:11341 6480464 Diclofenac results in decreased expression of SRD5A1 mRNA CTD PMID:26934552 dioxygen increases expression ISO RGD:11341 6480464 Oxygen deficiency results in increased expression of SRD5A1 mRNA CTD PMID:20880076 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of SRD5A1 mRNA CTD PMID:19560483 diuron increases expression EXP 6480464 Diuron results in increased expression of SRD5A1 mRNA CTD PMID:21551480 doxorubicin affects response to substance ISO RGD:736446 6480464 SRD5A1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression ISO RGD:736446 6480464 Doxorubicin results in increased expression of SRD5A1 mRNA CTD PMID:29803840 dutasteride decreases expression ISO RGD:736446 6480464 Dutasteride results in decreased expression of SRD5A1 mRNA CTD PMID:16806904 dutasteride decreases activity ISO RGD:736446 6480464 Dutasteride results in decreased activity of SRD5A1 protein CTD PMID:16806904 dydrogesterone decreases expression ISO RGD:736446 6480464 Dydrogesterone results in decreased expression of SRD5A1 mRNA CTD PMID:23183084 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SRD5A1 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:11341 6480464 epoxiconazole results in increased expression of SRD5A1 mRNA CTD PMID:22334560 epoxiconazole decreases expression ISO RGD:11341 6480464 epoxiconazole results in decreased expression of SRD5A1 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of SRD5A1 mRNA CTD PMID:17347304 fenthion increases expression ISO RGD:11341 6480464 Fenthion results in increased expression of SRD5A1 mRNA CTD PMID:34813904 finasteride decreases activity EXP 6480464 Finasteride results in decreased activity of SRD5A1 protein CTD PMID:20359488 finasteride multiple interactions ISO RGD:736446 6480464 [Finasteride co-treated with Testosterone] results in increased expression of SRD5A1 mRNA, [Finasteride co-treated with tributyltin co-treated with Testosterone] results in increased expression of SRD5A1 mRNA CTD PMID:23523586 finasteride decreases activity ISO RGD:736446 6480464 Finasteride results in decreased activity of SRD5A1 protein CTD PMID:8142312 , PMID:8689240 fluconazole decreases expression EXP 6480464 Fluconazole results in decreased expression of SRD5A1 mRNA CTD PMID:16643972 fluoroethene decreases activity ISO RGD:736446 6480464 vinyl fluoride analog results in decreased activity of SRD5A1 protein CTD PMID:8689240 flurbiprofen decreases expression EXP 6480464 Flurbiprofen results in decreased expression of SRD5A1 mRNA, Flurbiprofen results in decreased expression of SRD5A1 protein CTD PMID:31184881 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SRD5A1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:11341 6480464 [1 more ... CTD PMID:20938992 more ... folpet increases expression ISO RGD:11341 6480464 folpet results in increased expression of SRD5A1 mRNA CTD PMID:31558096 ganoderol B decreases activity EXP 6480464 ganoderol B results in decreased activity of SRD5A1 protein CTD PMID:17499997 genistein increases expression ISO RGD:11341 6480464 Genistein results in increased expression of SRD5A1 mRNA CTD PMID:32186404 hydroxyflutamide decreases expression ISO RGD:736446 6480464 hydroxyflutamide results in decreased expression of SRD5A1 mRNA CTD PMID:29556062 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SRD5A1 mRNA CTD PMID:21396975 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of SRD5A1 mRNA CTD PMID:18299717 isoflavones multiple interactions EXP 6480464 [selenomethylselenocysteine co-treated with Isoflavones] results in decreased activity of SRD5A1 protein CTD PMID:19025659 isotretinoin decreases expression ISO RGD:736446 6480464 Isotretinoin results in decreased expression of SRD5A1 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:11341 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of SRD5A1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SRD5A1 gene CTD PMID:20938992 , PMID:29127188 lead(0) affects expression ISO RGD:736446 6480464 Lead affects the expression of SRD5A1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:736446 6480464 Lead affects the expression of SRD5A1 mRNA CTD PMID:28903495 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of SRD5A1 mRNA CTD PMID:24136188 linuron decreases expression EXP 6480464 Linuron results in decreased expression of SRD5A1 mRNA CTD PMID:28705778 lipopolysaccharide decreases expression ISO RGD:11341 6480464 Lipopolysaccharides results in decreased expression of SRD5A1 mRNA CTD PMID:27339419 lycopene decreases expression EXP 6480464 lycopene results in decreased expression of SRD5A1 mRNA CTD PMID:15084515 methidathion increases expression ISO RGD:11341 6480464 methidathion results in increased expression of SRD5A1 mRNA CTD PMID:34813904 metoclopramide increases expression EXP 6480464 Metoclopramide results in increased expression of SRD5A1 mRNA CTD PMID:18978642 mitoxantrone affects response to substance ISO RGD:736446 6480464 SRD5A1 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SRD5A1 mRNA more ... CTD PMID:17602206 more ... N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of SRD5A1 mRNA CTD PMID:25380136 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of SRD5A1 mRNA CTD PMID:19716841 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SRD5A1 mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of SRD5A1 mRNA CTD PMID:24136188 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of SRD5A1 mRNA CTD PMID:23665939 ozone multiple interactions ISO RGD:11341 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SRD5A1 mRNA CTD PMID:34911549 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SRD5A1 mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SRD5A1 mRNA, Paraquat results in decreased expression of SRD5A1 protein CTD PMID:31128353 , PMID:32680482 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SRD5A1 mRNA CTD PMID:31610511 paraquat affects expression EXP 6480464 Paraquat affects the expression of SRD5A1 mRNA CTD PMID:31128353 PCB138 multiple interactions EXP 6480464 [3 more ... CTD PMID:19464308 perfluorododecanoic acid affects expression EXP 6480464 perfluorododecanoic acid affects the expression of SRD5A1 mRNA CTD PMID:33774092 perfluorooctane-1-sulfonic acid decreases activity EXP 6480464 perfluorooctane sulfonic acid results in decreased activity of SRD5A1 protein CTD PMID:28535922 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SRD5A1 mRNA, perfluorooctanoic acid results in decreased expression of SRD5A1 protein CTD PMID:19162173 , PMID:34958885 perfluorooctanoic acid decreases activity EXP 6480464 perfluorooctanoic acid results in decreased activity of SRD5A1 protein CTD PMID:28535922 perfluorooctanoic acid multiple interactions ISO RGD:11341 6480464 [perfluorooctanoic acid co-treated with Dietary Fats, Unsaturated] results in decreased expression of SRD5A1 mRNA CTD PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:11341 6480464 perfluorooctanoic acid results in decreased expression of SRD5A1 mRNA CTD PMID:17681415 , PMID:23626681 phenobarbital increases expression ISO RGD:11341 6480464 Phenobarbital results in increased expression of SRD5A1 mRNA CTD PMID:19363144 phenobarbital decreases expression ISO RGD:11341 6480464 Phenobarbital results in decreased expression of SRD5A1 mRNA CTD PMID:23091169 picoxystrobin decreases expression ISO RGD:736446 6480464 picoxystrobin results in decreased expression of SRD5A1 mRNA CTD PMID:33512557 piperidine decreases activity ISO RGD:736446 6480464 piperidine analog results in decreased activity of SRD5A1 protein CTD PMID:10896124 piperidine decreases activity EXP 6480464 piperidine analog results in decreased activity of SRD5A1 protein CTD PMID:10896124 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SRD5A1 mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO RGD:11341 6480464 pirinixic acid results in decreased expression of SRD5A1 mRNA CTD PMID:20813756 potassium dichromate multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of SRD5A1 protein CTD PMID:33675932 progesterone affects metabolic processing ISO RGD:11341 6480464 SRD5A1 protein affects the metabolism of Progesterone CTD PMID:15555913 progesterone increases reduction ISO RGD:736446 6480464 SRD5A1 protein results in increased reduction of Progesterone CTD PMID:25463305 progesterone multiple interactions ISO RGD:736446 6480464 [SRD5A1 protein results in increased metabolism of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:23183084 progesterone decreases expression ISO RGD:736446 6480464 Progesterone results in decreased expression of SRD5A1 protein CTD PMID:23183084 progesterone increases metabolic processing ISO RGD:736446 6480464 SRD5A1 protein results in increased metabolism of Progesterone CTD PMID:23183084 progesterone affects metabolic processing EXP 6480464 SRD5A1 protein affects the metabolism of Progesterone CTD PMID:15261307 progesterone decreases activity EXP 6480464 Progesterone analog results in decreased activity of SRD5A1 protein CTD PMID:20359488 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of SRD5A1 mRNA CTD PMID:16643972 propiconazole increases expression ISO RGD:11341 6480464 propiconazole results in increased expression of SRD5A1 mRNA CTD PMID:22334560 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SRD5A1 mRNA CTD PMID:28374803 Se-methyl-L-selenocysteine multiple interactions EXP 6480464 [selenomethylselenocysteine co-treated with Isoflavones] results in decreased activity of SRD5A1 protein CTD PMID:19025659 Se-methylselenocysteine multiple interactions EXP 6480464 [selenomethylselenocysteine co-treated with Isoflavones] results in decreased activity of SRD5A1 protein CTD PMID:19025659 silicon dioxide decreases expression ISO RGD:736446 6480464 Silicon Dioxide results in decreased expression of SRD5A1 mRNA CTD PMID:25351596 silver atom increases expression EXP 6480464 Silver analog results in increased expression of SRD5A1 mRNA, Silver analog results in increased expression of SRD5A1 protein CTD PMID:27746313 silver(0) increases expression EXP 6480464 Silver analog results in increased expression of SRD5A1 mRNA, Silver analog results in increased expression of SRD5A1 protein CTD PMID:27746313 sodium arsenite increases methylation ISO RGD:11341 6480464 sodium arsenite results in increased methylation of SRD5A1 gene CTD PMID:32068019 streptozocin multiple interactions ISO RGD:11341 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of SRD5A1 mRNA CTD PMID:29127188 sulpiride increases expression EXP 6480464 Sulpiride results in increased expression of SRD5A1 mRNA CTD PMID:18978642 sunitinib decreases expression ISO RGD:736446 6480464 Sunitinib results in decreased expression of SRD5A1 mRNA CTD PMID:31533062 tebufenpyrad decreases expression ISO RGD:736446 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SRD5A1 mRNA CTD PMID:33512557 terbutylazine decreases expression ISO RGD:11341 6480464 terbutylazine results in decreased expression of SRD5A1 mRNA CTD PMID:23591565 testosterone multiple interactions ISO RGD:736446 6480464 [Finasteride co-treated with Testosterone] results in increased expression of SRD5A1 mRNA more ... CTD PMID:21688280 , PMID:23523586 testosterone multiple interactions EXP 6480464 [SRD5A1 protein results in increased metabolism of Testosterone] which results in increased chemical synthesis of Dihydrotestosterone CTD PMID:28535922 testosterone increases metabolic processing EXP 6480464 SRD5A1 protein results in increased metabolism of Testosterone CTD PMID:28535922 testosterone increases expression ISO RGD:736446 6480464 Testosterone results in increased expression of SRD5A1 mRNA CTD PMID:23523586 , PMID:33359661 testosterone increases expression EXP 6480464 Testosterone results in increased expression of SRD5A1 mRNA CTD PMID:22131296 tetrachloromethane decreases expression ISO RGD:11341 6480464 Carbon Tetrachloride results in decreased expression of SRD5A1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SRD5A1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SRD5A1 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SRD5A1 mRNA CTD PMID:23411599 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SRD5A1 mRNA CTD PMID:28943392 topotecan affects response to substance ISO RGD:736446 6480464 SRD5A1 protein affects the susceptibility to Topotecan CTD PMID:16217747 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of SRD5A1 mRNA CTD PMID:19423681 tributylstannane decreases activity ISO RGD:736446 6480464 tributyltin results in decreased activity of SRD5A1 protein CTD PMID:12231121 tributylstannane multiple interactions ISO RGD:736446 6480464 [Finasteride co-treated with tributyltin co-treated with Testosterone] results in increased expression of SRD5A1 mRNA, [tributyltin co-treated with Testosterone] results in increased expression of SRD5A1 mRNA CTD PMID:23523586 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SRD5A1 mRNA CTD PMID:19448997 Triptolide decreases expression ISO RGD:11341 6480464 triptolide results in decreased expression of SRD5A1 mRNA CTD PMID:32835833 urethane increases expression ISO RGD:736446 6480464 Urethane results in increased expression of SRD5A1 mRNA CTD PMID:28818685 vincaleukoblastine affects response to substance ISO RGD:736446 6480464 SRD5A1 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin multiple interactions ISO RGD:736446 6480464 AR protein affects the reaction [vinclozolin inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A1 mRNA]], vinclozolin inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A1 mRNA] CTD PMID:25324206 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SRD5A1 mRNA CTD PMID:23034163 vitamin E affects expression EXP 6480464 Vitamin E affects the expression of SRD5A1 mRNA CTD PMID:20447326 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of SRD5A1 mRNA CTD PMID:29669061 zearalenone decreases activity EXP 6480464 Zearalenone results in decreased activity of SRD5A1 protein CTD PMID:29669061 zinc atom increases expression EXP 6480464 Zinc results in increased expression of SRD5A1 mRNA CTD PMID:18172885 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of SRD5A1 mRNA CTD PMID:18172885 ziram decreases expression EXP 6480464 Ziram results in decreased expression of SRD5A1 mRNA CTD PMID:30422632